000 01439 a2200397 4500
005 20250517043320.0
264 0 _c20150728
008 201507s 0 0 eng d
022 _a1936-0541
024 7 _a10.1007/s12072-014-9555-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShiffman, Mitchell L
245 0 0 _aExtended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.
_h[electronic resource]
260 _bHepatology international
_cOct 2014
300 _a517-26 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aCheinquer, Hugo
700 1 _aBerg, Christoph P
700 1 _aBerg, Thomas
700 1 _ade Figueiredo-Mendes, Cláudio
700 1 _aDore, Gregory J
700 1 _aFerraz, Maria Lúcia
700 1 _aMendes-Corrêa, Maria Cássia
700 1 _aLima, Maria Patelli
700 1 _aParise, Edison R
700 1 _aRios, Alma Minerva Perez
700 1 _aReuter, Tania
700 1 _aSanyal, Arun J
700 1 _aShafran, Stephen D
700 1 _aHohmann, Marc
700 1 _aTatsch, Fernando
700 1 _aBakalos, George
700 1 _aZeuzem, Stefan
773 0 _tHepatology international
_gvol. 8
_gno. 4
_gp. 517-26
856 4 0 _uhttps://doi.org/10.1007/s12072-014-9555-3
_zAvailable from publisher's website
999 _c25101361
_d25101361